ERBB2 and breast carcinoma: Between 15% and 20% of breast cancers show overexpression or gene amplification of the human epidermal growth factor receptor 2 (HER2), a trans-membrane receptor protein at the head of an intracellular tyrosine kinase signalling cascade.